cognitive cybersecurity intelligence

News and Analysis


What the DEA does not understand or does not care about medication cessation decisions

The US Drug Enforcement Administration (DEA) is focusing on the wrong metrics by restricting the use of opioid pain medications and prosecuting doctors over the potential risk of drug diversion, says L. Joseph Parker. He argues that this approach has contributed to patient deaths and forced many to seek pain relief from unofficial sources, including counterfeit pills containing fentanyl. Parker calls for medical personnel, rather than law enforcement, to determine medication quotas.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

Connecting Tech to Black America

Tech evangelist David Lee spotlights the underrepresentation of Black Americans in tech, an issue he contends requires collective action to rectify. He suggests fostering connections

Zero-Day Attack Hits Cybersecurity Leader

The MITRE Corporation, a contributor to public interest cybersecurity, disclosed a data breach originating from a state-backed hack. Detected after suspicous activity was noticed on

Defining and Understanding Trust Assurance

Trust is essential for businesses and building it requires embracing the pillars of trust assurance: predictive, integrated, and transparent systems. Through trust assurance, businesses can